Informace o projektu
MEDGENET - Medical genomics and epigenomics network
(MEDGENET)
- Kód projektu
- 692298
- Období řešení
- 1/2016 - 12/2018
- Investor / Programový rámec / typ projektu
-
Evropská unie
- Horizon 2020
- Spreading excellence and widening participation
- Fakulta / Pracoviště MU
- Středoevropský technologický institut
- Spolupracující organizace
-
European Molecular Biology Laboratory
Uppsala universitet
Ethniko Kentro Erevnas Kai Technologikis
The main goal of MEDGENET consortium is to use synergies and existing expertise in EU leading institutions such as EMBL, Uppsala University and CERTH to reinforce the productivity and competitiveness of the CEITEC in the field of medical genomics and epigenomics. We propose clear strategy based on combination of unique complementary skills present in partner institutions that will transform CEITEC into a key leader in the field. ERA Chair who recently joint CEITEC already initiated the transformational change of the institute and TWINNING framework will further support sharing her international contacts with other CEITEC researchers. MEDGENET aims to create well-educated taskforce of biomedical researchers, who will notably contribute to the development of new genomics and bioinformatics tools and their application in clinical practice. Proposed project will enable to establish the best practices for performing innovative and high-quality biomedical research and to strengthen CEITEC´s competence to translate the research results into high value-added clinical applications. Stimulation of knowledge exchange, implementation of cutting edge technologies and mastery of modern genomics and bioinformatics methodologies will have a direct impact on the overall research and innovation potential of CEITEC and will increase its visibility in the international scientific community.
Publikace
Počet publikací: 52
2018
-
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets 1 and 2 treated with chemo(immuno)therapy
haematologica, rok: 2018, ročník: 103, vydání: 4, DOI
-
Promoter methylation of ROR1 ligand WNT5A associates with its expression in CLL
Rok: 2018, druh: Konferenční abstrakty
-
ToTem: a tool for variant calling pipeline optimization
BMC Bioinformatics, rok: 2018, ročník: 19, vydání: JUN, DOI
-
Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling
Rok: 2018, druh: Konferenční abstrakty
2017
-
Basic domain of telomere guardian TRF2 reduces D-loop unwinding whereas Rap1 restores it
Nucleic Acids Research, rok: 2017, ročník: 45, vydání: 21, DOI
-
BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.
Rok: 2017, druh: Konferenční abstrakty
-
Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency
Rok: 2017, druh: Konferenční abstrakty
-
GLASS
Rok: 2017
-
GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data
Bioinformatics, rok: 2017, ročník: 33, vydání: 23, DOI
-
GLASS:assisted and standardized assessment of gene variations from Sanger sequence trace data.
Rok: 2017, druh: Konferenční abstrakty